Resmed (RMD) Receivables - Net (2010 - 2026)

Resmed's Receivables - Net history runs 17 years deep, the most recent figure standing at $998.8 million for Q1 2026.

• Quarterly Receivables - Net rose 10.03% year-over-year to $998.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $998.8 million (up 10.03% YoY) and the FY2025 annual result came in at $939.5 million, up 12.21% from the prior year.
• Receivables - Net was $998.8 million for Q1 2026 at Resmed, up from $985.6 million in the prior quarter.
• Across five years, Receivables - Net topped out at $998.8 million in Q1 2026 and bottomed at $508.6 million in Q1 2022.
• A 5-year average of $777.5 million and a median of $779.3 million in 2024 frame the typical range for Receivables - Net.
• Annual changes were most pronounced in 2022 — Receivables - Net dropped 6.24% — and 2023, when it soared 34.94%.
• Resmed's Receivables - Net stood at $672.3 million in 2022, then advanced by 8.55% to $729.7 million in 2023, then rose by 17.84% to $859.9 million in 2024, then advanced by 14.62% to $985.6 million in 2025, then advanced by 1.34% to $998.8 million in 2026.
• Business Quant data shows RMD's Receivables - Net at $998.8 million in Q1 2026, $985.6 million in Q4 2025, and $907.3 million in Q3 2025.